Cases 61 - 70 of 587
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al
as 3:2023cv00022
Plaintiff:
CHIESI USA INC. and CHIESI FARMACEUTICI S.P.A.
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED), EUGIA US LLC and AUROBINDO PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
COBERLY v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv07450
Plaintiff:
David Coberly
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
COHEN v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv07349
Plaintiff:
Larry K Cohen and LARRY K. COHEN
Defendant:
AUROBINDO PHARMA, LTD., SOLCO HEALTHCARE U.S., LLC, JOHN DOE and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BLAIR v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06632
Plaintiff:
CINDY LOU BLAIR
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06466
Plaintiff:
DERWIN BAKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HARDWICK v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06397
Plaintiff:
DIANE HARDWICK
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
TSAKALAS v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06294
Plaintiff:
DEBORAH TSAKALAS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MOTTIE v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06304
Plaintiff:
MAURICE MOTTIE
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMITH v. MYLAN PHARMACEUTICALS INC. et al
as 1:2022cv06229
Plaintiff:
Deborah Smith
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GRAY v. AUROBINDO PHARMA LTD. et al
as 1:2022cv06153
Plaintiff:
LOUISE GRAY
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA U.S.A., INC., SCIEGEN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1446 pl Notice for Removal - Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
